The Global
Health Innovative Technology Fund (GHIT Fund) is a public-private partnership
dedicated to the field of global health. It is a partnership between five
Japanese pharmaceutical companies, the government of Japan and the Bill &
Melinda Gates Foundation and aims to facilitate global partnerships between
Japanese and non-Japanese research and development organizations and fund
promising research programs in order to realize advances in new health
technologies by Japanese pharmaceutical companies, universities and research
institutions possessing strengths in drug creation.
One of its
objective is to use those technologies effectively in emerging countries and the
developing world.
Aucun commentaire:
Enregistrer un commentaire